Holding at a dose for an extra 4 weeks before escalating is a medically supported strategy when: Nausea or vomiting persists beyond 2 weeks at the current dose You are unable to eat at least 1,000 calories per day comfortably Dehydration symptoms appear (dark urine, dizziness on standing, dry mouth) You are losing weight faster than 1 to 2 pounds per week on the current dose (aggressive weight loss increases side effect risk) In the STEP trials, delayed escalation did not compromise overall weight loss outcomes at 68 weeks
While Ozempic might appear attractive for weight loss because of its GLP-1 component, it is only approved for diabetes management
The two drugs have generated billions of dollars in profits for the company, but that cash stream will start to dry up next year when semaglutide patents expire in some of the worlds biggest markets, including India, China, and Brazil
Medications such as semaglutide, best known under the brand name Ozempic, have transformed the treatment of obesity and metabolic disease
.jpg)
